Clinical risk prevention indicators in preimplantation genetic testing
10.3760/cma.j.cn101441-20240311-00090
- VernacularTitle:胚胎植入前遗传学检测技术临床风险防范指标
- Author:
Xiaokun HU
1
;
Yanwen XU
1
Author Information
1. 中山大学附属第一医院生殖医学中心 广东省妇产疾病临床医学研究中心 广东省生殖医学重点实验室，广州 510080
- Publication Type:Journal Article
- Keywords:
Preimplantation genetic testing;
Risk indicator;
Prevention
- From:
Chinese Journal of Reproduction and Contraception
2024;44(7):691-695
- CountryChina
- Language:Chinese
-
Abstract:
With the rapid development of preimplantation genetic testing (PGT) technology in recent years, risks in clinical application have arisen at the same time. Related risks include identification of pathogenic variants for PGT, negative impact of disease for PGT on ovarian reservation in female carriers, control of ovarian stimulation, and safety of ovarian simulation in hereditary cancer gene carriers. Risk management should be performed in different steps of the PGT processes.
